TR200001393T2 - Azelain asitli terkip. - Google Patents

Azelain asitli terkip.

Info

Publication number
TR200001393T2
TR200001393T2 TR2000/01393T TR200001393T TR200001393T2 TR 200001393 T2 TR200001393 T2 TR 200001393T2 TR 2000/01393 T TR2000/01393 T TR 2000/01393T TR 200001393 T TR200001393 T TR 200001393T TR 200001393 T2 TR200001393 T2 TR 200001393T2
Authority
TR
Turkey
Prior art keywords
azelain
acidic composition
composition
acid
triacylglycerides
Prior art date
Application number
TR2000/01393T
Other languages
English (en)
Inventor
Franke Patrick
Gunther Clemens
Riedl Jutta
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27217979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200001393(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of TR200001393T2 publication Critical patent/TR200001393T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Abstract

Bulus asagidaki içerik maddelerini ihtiva eden farmakolojik bir terkiple ilgilidir: azelain asit, poliakrilik asit, triasilgliseridler, propilenglikol, polisorbatlar, soya lesitin, su ve tuzlar. Terkip rozasea, yaslanma nedenli deri bozukluklari, melasma, akne ve/veya deri iritasyonlarinin tedavisinde kullanilmaga uygun bir hidrojeldir.
TR2000/01393T 1997-11-19 1998-11-18 Azelain asitli terkip. TR200001393T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19753044 1997-11-19
US7485098P 1998-02-12 1998-02-12
DE19808086 1998-02-20

Publications (1)

Publication Number Publication Date
TR200001393T2 true TR200001393T2 (tr) 2000-10-23

Family

ID=27217979

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01393T TR200001393T2 (tr) 1997-11-19 1998-11-18 Azelain asitli terkip.

Country Status (21)

Country Link
US (1) US6534070B1 (tr)
EP (1) EP1032379B1 (tr)
JP (1) JP3867123B2 (tr)
KR (1) KR100534511B1 (tr)
AT (1) ATE210438T1 (tr)
AU (1) AU743437B2 (tr)
BR (1) BR9814214B1 (tr)
CA (1) CA2311128C (tr)
CZ (1) CZ299116B6 (tr)
DE (2) DE59802473D1 (tr)
DK (1) DK1032379T3 (tr)
ES (1) ES2169566T3 (tr)
HU (1) HU226592B1 (tr)
IL (1) IL136101A (tr)
IS (1) IS2257B (tr)
NO (1) NO327712B1 (tr)
PL (1) PL202454B1 (tr)
PT (1) PT1032379E (tr)
SK (1) SK284338B6 (tr)
TR (1) TR200001393T2 (tr)
WO (1) WO1999025332A1 (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026982A1 (en) * 2003-06-10 2005-02-03 Soenke Johannsen Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
WO2004108143A1 (de) * 2003-06-10 2004-12-16 Schering Aktiengesellschaft Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff
DE50305909D1 (de) * 2003-10-13 2007-01-18 Salama Zoser B Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze
DE10356288B4 (de) 2003-11-28 2014-04-03 Siemens Aktiengesellschaft Röntgendetektorlade
EP1861067A2 (en) * 2005-03-09 2007-12-05 Combe Incorporated Stable mixed emulsions comprising semisolid dispersions of at least two discrete and distinctly different particle size ranges
EP1926466A2 (en) * 2005-09-19 2008-06-04 Combe Incorporated Stable emulsion systems with high salt tolerance
KR100861978B1 (ko) * 2007-03-22 2008-10-07 한국콜마 주식회사 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
EP2201930A1 (en) * 2008-12-23 2010-06-30 Intendis GmbH Hydrogel composition for the treatment of dermatological disorders
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
PL217786B1 (pl) * 2009-05-28 2014-08-29 P P F Hasco Lek Spółka Akcyjna Żel z kwasem azelainowym i sposób wytwarzania żelu z kwasem azelainowym
CN102770162B (zh) 2009-08-21 2016-09-28 靶向递送技术有限公司 囊泡制剂
DE102010021671A1 (de) * 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
GB201205642D0 (en) * 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
GB201208409D0 (en) * 2012-05-14 2012-06-27 Sequessome Technology Holdings Ltd Vesicular formulations, kits and uses
ES2895910T3 (es) 2015-06-30 2022-02-23 Sequessome Tech Holdings Limited Composiciones multifásicas
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811081A1 (de) 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
ATE117665T1 (de) * 1990-11-14 1995-02-15 Oreal Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
GB9316323D0 (en) * 1993-08-06 1993-09-22 Procter & Gamble Cosmetic compositions
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5547989A (en) 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US5618522A (en) * 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
UY24246A1 (es) 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado

Also Published As

Publication number Publication date
AU743437B2 (en) 2002-01-24
BR9814214A (pt) 2000-10-03
JP3867123B2 (ja) 2007-01-10
WO1999025332A1 (de) 1999-05-27
IS2257B (is) 2007-06-15
PL202454B1 (pl) 2009-06-30
PT1032379E (pt) 2002-06-28
JP2001522879A (ja) 2001-11-20
IL136101A (en) 2005-08-31
CA2311128A1 (en) 1999-05-27
CZ20001844A3 (cs) 2000-10-11
US6534070B1 (en) 2003-03-18
AU1755199A (en) 1999-06-07
HUP0004375A2 (hu) 2001-08-28
NO327712B1 (no) 2009-09-14
NO20002487D0 (no) 2000-05-12
ES2169566T3 (es) 2002-07-01
IL136101A0 (en) 2001-05-20
DE59802473D1 (de) 2002-01-24
EP1032379A1 (de) 2000-09-06
SK284338B6 (sk) 2005-02-04
NO20002487L (no) 2000-07-18
PL340631A1 (en) 2001-02-12
HU226592B1 (en) 2009-04-28
IS5484A (is) 2000-05-09
SK7082000A3 (en) 2001-06-11
CZ299116B6 (cs) 2008-04-30
EP1032379B1 (de) 2001-12-12
CA2311128C (en) 2008-01-29
KR20010032229A (ko) 2001-04-16
ATE210438T1 (de) 2001-12-15
KR100534511B1 (ko) 2005-12-08
HUP0004375A3 (en) 2006-06-28
DK1032379T3 (da) 2002-04-02
DE19881737D2 (de) 2001-03-22
BR9814214B1 (pt) 2010-07-13

Similar Documents

Publication Publication Date Title
TR200001393T2 (tr) Azelain asitli terkip.
BR0111358A (pt) Compostos de tioacetamida e seu uso
ID25921A (id) Sulfonamida-sulfonamida untuk pengobatan penyakit-penyakit yang dimediakan endotelin
BR0207663A (pt) Uso de inibidores de egfr naturais para prevenir os efeitos colaterais devido à terapia com retinóides, sabões e outros estìmulos que ativam o receptor do fator de crescimento epidérmico
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ATE300597T1 (de) Behandlung von geweben
TR199800815A2 (tr) Sülfonilaminokarbonasitler.
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
BR0008266A (pt) Método para efetuar branqueamento elevado dos dentes
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
NO20043661L (no) Bipolare trans-karotenoidsalter og deres anvendelser
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
CA2245206A1 (fr) Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
IS5505A (is) Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
PT1035859E (pt) Utilizacao de complexos de fosfolipidos de extractos de vitis vinifera como agentes anti-ateroescleroticos
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
NO20022920L (no) Nye forbindelser
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
DE60115944D1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-karnitin und alkanoyl-l-karnitin mit taurinchlorid enthalten
DE60127436D1 (de) Zusammensetzungen enthaltend beta-galactosidase, n-acetyl-glucosaminidase und n-acetyl-galactosaminidase, die keine protease enthalten
DE50208206D1 (de) Verwendung von Salicylsäure und Glyzyrrhetinsäure enhaltende Zusammensetzungen zur Aknebehandlung
ATE399551T1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin